The Preclinical Research Process
IDEA TO PRODUCT: THE PROCESS(1996)
摘要
The preclinical research process extends from early assessments of feasibility of pharmaceutical development to providing
regulatory authorities and clinical trial units with information necessary for administering the product to human subjects.
Chief concerns include safety, which is evaluated in well-defined preclinical toxicology programs, and efficacy, which must
be defined in appropriate in vitro systems and animal models prior to entering the clinic. Pharmacological characterization
in animal models defines activity and identifies site(s) and mechanism of action, effective dose range, optimal treatment
regimens (route and frequency of administration), and quantifiable endpoints for monitoring the pharmacodynamic behavior of
the drug in vivo. Results from these studies permit the toxicological studies to focus on relevant animal models and target
tissues. They can also reveal new or modified activities for further safety assessment and examination in clinical trials.
New experimental models and analytical methodologies often have to be developed and validated for the specific product under
evaluation.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要